News

In June 2023 ReproUnion was awarded 6.7 million euros to promote innovation in research and treatment of infertility, by establishing an innovation platform with new opportunities to reduce the risk of involuntary childlessness and improve fertility treatment.

The first fertility counselling clinic opened at Rigshospitalet in 2011 with support from ReproUnion. Now the Independent Research Fund Denmark has granted DKK 2 million to Anja Pinborg to investigate whether a decade with 3,700 consultations have led to different family formation patterns.

With the funding the research project wants to show that testicular tissue and spermatogenic stem cells can be frozen and transplanted back into the same man to restore fertility. In this way, both men with non-obstructive azoospermia and long-term survivors of childhood cancer will have an opportunity to have children of their own.

At the ReproUnion Summit on 2 September 2022, the public-private partnership celebrated a decade of multi-disciplinary collaboration to overcome infertility and took a future perspective to continue building the next generation of reproductive researchers, as well as to build capacity by supporting the scale up of innovative ideas in collaboration with start-ups and other companies in the field of reproduction.

The 38th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in Milan, welcomed an audience of over 10 000 to discuss innovations within reproductive science...

On 16-19 June 2022 close to 100.000 people stopped by Folkemødet – the Danish democracy festival with 2500 debates and events! In a fully packed tent Søren Ziebe sat the scene for an engaging panel discussion on the topic: Involuntary childlessness steals dreams – and labour! Moderator Peter Qvortrup Geisling secured a very engaging debate and involvement from the audience!

Close to 100 delegates participated in the conference with symposia, poster walks and a battle-style debate between Principal Investigators in different disciplines of reproductive medicine. There was plenty of airtime for young researchers as well as excellent networking and the sharing of knowledge and the conference turned out as a great showcase to attract new members to ReproYoung!

Bringing together experts from different disciplines holds a huge potential when it comes to achieving major breakthroughs in science. To drive such interdisciplinary research in male reproduction, the Novo Nordisk Foundation has awarded ReproUnion researcher Kristian Almstrup two major grants.

The study associates assisted reproduction with an increased risk of complications during pregnancy, especially in women aged 35 years or older and those with pre-existing health problems. However, participants in the study were pooled into one group, not distinguishing between different fertility treatments and the techniques used nor between singletons and twin births.

Barbara Sahlin has successfully defended her PhD and a key outcome of the study is the identification of three candidate protein markers of androgen activity, which she hopes can be a tool to better determine testosterone deficiency. Testosterone is crucial for reproductive function.